851 related articles for article (PubMed ID: 24113620)
1. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
[TBL] [Abstract][Full Text] [Related]
2. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
3. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
[TBL] [Abstract][Full Text] [Related]
5. Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
Chung PH; Krabbe LM; Darwish OM; Westerman ME; Bagrodia A; Gayed BA; Haddad AQ; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2014 Oct; 32(7):981-8. PubMed ID: 25022858
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
7. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
8. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
9. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
10. Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes.
Rink M; Xylinas E; Trinh QD; Lotan Y; Margulis V; Raman JD; Fisch M; Lee RK; Chun FK; Abdennabi J; Seitz C; Pycha A; Zlotta AR; Karakiewicz PI; Babjuk M; Scherr DS; Shariat SF;
BJU Int; 2013 Sep; 112(5):623-37. PubMed ID: 23465088
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
Bagrodia A; Kuehhas FE; Gayed BA; Wood CG; Raman JD; Kapur P; Derweesh IH; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
Urology; 2013 May; 81(5):972-7. PubMed ID: 23523292
[TBL] [Abstract][Full Text] [Related]
13. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration.
Fairey AS; Kassouf W; Estey E; Tanguay S; Rendon R; Bell D; Izawa J; Chin J; Kapoor A; Matsumoto E; Black P; So A; Lattouf JB; Saad F; Drachenberg D; Cagiannos I; Lacombe L; Fradet Y; Jacobsen NE
BJU Int; 2013 Oct; 112(6):791-7. PubMed ID: 23148712
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
15. Poor Preoperative Glycemic Control Is Associated with Dismal Prognosis after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Korean Multicenter Study.
Kang SG; Hwang EC; Jung SI; Yu HS; Chung HS; Kang TW; Kwon DD; Hwang JE; Kim JS; Noh JH; You JH; Kim MK; Oh TH; Seo IY; Baik S; Kim CS; Kang SH; Cheon J
Cancer Res Treat; 2016 Oct; 48(4):1293-1301. PubMed ID: 27034146
[TBL] [Abstract][Full Text] [Related]
16. Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?
Raman JD; Shariat SF; Karakiewicz PI; Lotan Y; Sagalowsky AI; Roscigno M; Montorsi F; Bolenz C; Weizer AZ; Wheat JC; Ng CK; Scherr DS; Remzi M; Waldert M; Wood CG; Margulis V;
Urol Oncol; 2011; 29(6):716-23. PubMed ID: 20056458
[TBL] [Abstract][Full Text] [Related]
17. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
[TBL] [Abstract][Full Text] [Related]
18. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
19. Oncologic outcomes and survival in pT0 tumors after radical nephroureterectomy for upper tract urothelial carcinoma: results from of a large multicenter international collaborative study.
Rouprêt M; Xylinas E; Colin P; Kluth L; Karakiewicz P; Shariat SF
Eur Urol; 2013 Feb; 63(2):404-5. PubMed ID: 23040206
[No Abstract] [Full Text] [Related]
20. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
